HERBESPRIT
LIVE

Serial Number

79382958

Owner

VISA DE CHINE

Attorney

Andrew W. Chu

Filing Date

Aug 11, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HERBESPRIT Trademark

Serial Number: 79382958 • Registration: 7554334

HERBESPRIT is a trademark filed by VISA DE CHINE on August 11, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 34 (Smokers Articles). The application is currently registered and active.

Owner Contact Info

VISA DE CHINE

24 Avenue du Général de Gaulle

Entity Type: 99

Trademark Details

Filing Date

August 11, 2023

Registration Date

November 5, 2024

Published for Opposition

August 20, 2024

Goods & Services

Nutritional supplements; food supplements; vitamin supplements; nutritional mineral supplements; plant-based food supplements; mineral-based food supplements; anti-oxidant food supplements; food supplements in the form of liquid, gel capsules, tablets, powder, capsules, pills, sachets; food supplements with cosmetic effects; royal jelly food supplements; nutritional and food supplements; dietary supplements for persons with special diets; therapeutic food supplements containing ginseng; therapeutic food supplements containing red ginseng; liquid herb-based supplements; mineral food supplements; herb-based supplements; dietetic food and beverages adapted for medical use; medicinal substances for medical use, namely, herbs for medicinal purposes; Chinese traditional medicinal substances, namely, medicines made of Chinese traditional medicinal herbs; Chinese traditional medicinal substances based on goji, astragalus, dong quai, notoginseng, cordyceps, ginger and saffron for boosting energy, improving cognitive function and enhancing immune system function; Chinese traditional medicinal preparations, namely, Chinese traditional medicinal herbs; medicinal herbal teas; pearl powder for medical use; medicinal roots; medicinal herbs; herb-based compositions for medical use; extracts of medicinal herbs, other than essential oils; plant extracts for medical use, other than essential oils; plant and herb extracts for medicinal use, other than essential oils; nutritional drink supplements for medical use in the nature of liquid, gel capsules, tablets, powder, capsules, pills, sachets; herbalism products, namely, medicinal plant extracts other than essential oils, for pharmaceutical purposes; ginseng-based foodstuffs adapted for medical use; food products based on red ginseng adapted for medical use, namely, for boosting energy, improving cognitive function and enhancing immune system function; food products based on goji, astragalus, dong quai, notoginseng, cordyceps, ginger and saffron adapted for medical use, namely, for boosting energy, improving cognitive function and enhancing immune system function; medicated bath preparations for medical use; medicinal soaps; medicated shampoos; medicated dentifrices; mugwort sticks for medical purposes, namely, moxibustion; mugwort rolls for medical purposes, namely, moxibustion; jujube for medical use; medicated jujube paste; ginseng for medicinal use; ginseng capsules for medical use; medicines made from traditional Chinese medicinal herbs, namely, for boosting energy, improving cognitive function and enhancing immune system function; medicine made of traditional Chinese herbs; medicine made of traditional Tibetan herbs; tonics being medicines, for boosting energy, improving cognitive function and enhancing immune system function; medicinal drinks; food supplements, namely, plant-based anti-oxidants; nutraceutical preparations for therapeutic or medical use for boosting energy, improving cognitive function and enhancing immune system function; medicinal beverages in the nature of herbal teas, herbal beverages, herbal tinctures, antioxidant enriched fruit juices; syrups for pharmaceutical use for boosting energy, improving cognitive function and enhancing immune system function; medicinal liqueurs, namely, liquid herbal supplements containing ginseng, goji berry, angelica sinensis, astragalus, chrysanthemum, jujube, licorice, longan, ganoderma, Chinese wolfberry; extracts of medicinal products, other than essential oils, namely, medicinal herb extracts containing ginseng, goji berry, angelica sinensis, astragalus, chrysanthemum, jujube, licorice, longan, ganoderma, Chinese wolfberry; medical dressings; medical dressings; antibiotic ointments for medical use; dry extracts and powders for pharmaceutical use, namely, ginseng dry extract, astragalus powder, goji berry dry extract, angelica sinensis powder, licorice dry extract, reishi mushroom powder, chrysanthemum dry extract, jujube powder, longan dry extract, Chinese wolfberry powder

Cosmetic products in the nature of make-up and non-medicated skin, body, hair, nail and lip care preparations; cosmetic products for the face in the nature of non-medicated skin care preparations; cosmetic products for skin care in the nature of non-medicated skin care preparations; cosmetic creams; cosmetic gels; cosmetic milks; cosmetic lotions; anti-aging skin care preparation, namely, anti-aging toner; anti-aging cleansing and moisturizing gel; anti-aging skin lotion; non-medicated anti-aging serums; anti-aging moisturizers; facial cleansing milk; essential oils; plant-based essential oils; cosmetic oils; non-medicated soaps; cosmetic hair care products in the nature of non-medicated hair care preparations, hair shampoos and hair conditioners; cosmetic products for the body in the nature of cosmetic preparations for body care; cosmetic products in the nature of skin creams in liquid form, gel capsules containing non-medicated skin care preparations, sachets containing non-medicated skin care preparations for skin hydration, anti-aging, skin brightening, wrinkle reduction, lightening of skin dark spots, improving skin elasticity, evening out skin tone, sebum control, and soothing skin irritation; flower extracts being perfumes; extracts of flowers being perfumes; beard care products in the nature of non-medicated beard creams, lotions, oils, waxes and cleaners; non-medicated beard care preparations, namely, beard balms and lotions; non-medicated skincare preparations, namely, body mist; beauty masks; herbalism products for cosmetology in the nature of non-medicated herbal body care products, namely, body oils, salves, and lip balms; perfumes; dentifrices; make-up removing preparations; lipstick; shaving products, namely, shaving preparations; sets of shaving products comprising shaving creams and after-shave lotions

Tobacco; articles for use with tobacco, namely, ashtrays, cigar cutters, cigar humidors, cigar lighters, cigar and cigarette boxes, cigarette lighters, cigarette rolling papers, electronic cigarettes and oral vaporizers for smokers, hookahs, smoking pipes; tobacco and tobacco substitutes; cigarettes; tobacco-free, herbal-based cigarettes; herbal-based electronic cigarettes; cigarettes containing tobacco substitutes, not for medical use; cigarettes containing tobacco substitutes; herbal molasses for use as a tobacco substitute; tobacco substitutes; plant-based tobacco substitutes; pipes for smoking mentholated tobacco substitutes; flavorings, other than essential oils, for tobacco substitutes; devices for heating tobacco substitutes intended for inhalation; liquid nicotine solutions for electronic cigarettes; electronic cigarette liquid (e-liquid) consisting of flavorings in the nature of liquid, other than essential oils, used for refilling electronic cigarette cartridges containing CBD derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent; liquids for electronic cigarettes (e-liquids) consisting of propylene glycol; liquids for electronic cigarettes (e-liquid) composed of vegetable glycerin; cannabis waxes for smoking, not being essential oils for use in oral vaporizers for smoking; all of the aforesaid products containing CBD derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent, for smoking purposes; disposable oral vaporizers for smokers, sold empty and marketed and intended for use with CBD derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent, for smoking purposes; electronic oral vaporizers for smokers sold empty, namely, electronic cigarettes, marketed and intended for use with CBD derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent, for smoking purposes; oral vaporizers for smoking purposes, marketed and intended for use with CBD derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent, for smoking purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 3, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 26, 2025 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Apr 10, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 10, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 8, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 8, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2024 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 6, 2024 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 11, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 11, 2024 CNEA
ASSIGNED TO EXAMINER
Jun 26, 2024 DOCK
ASSIGNED TO EXAMINER
Jun 25, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2024 TROA
REFUSAL PROCESSED BY IB
May 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 25, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 12, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 11, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 18, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 14, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 9, 2023 REPR